keyword
https://read.qxmd.com/read/38234934/how-should-complicated-cases-of-thrombotic-thrombocytopenic-purpura-with-positive-coombs-test-be-treated
#21
Moutaz Ghrewati, Anas Mahmoud, Tala Beliani, Karam Zakharia, Mehandar Kumar
Thrombocytopenia with concomitant anemia is a serious condition with a high mortality risk. Destruction of platelets, i.e., thrombocytopenia, can be secondary to either auto-antibodies (immune-mediated) or mechanical destruction (non-immune-mediated). The Coombs test is a widespread tool to differentiate between the two categories, resulting in different specific treatment approaches for each diagnosis. A peripheral blood smear can also help make the diagnosis; for instance, in cases of mechanical destruction such as thrombotic thrombocytopenic purpura (TTP), the red blood cell (RBC) shape looks fragmented, forming schistocytes...
December 2023: Curēus
https://read.qxmd.com/read/38227937/how-i-treat-long-term-survivors-of-childhood-acute-leukemia
#22
JOURNAL ARTICLE
Paul Saultier, Gérard Michel
The population of childhood leukemia survivors who reach adulthood is growing due to improved therapy. However, survivors are at risk of long-term complications. Comprehensive follow-up programs play a key role in childhood leukemia survivor care. The major determinant of long-term complications is the therapeutic burden accumulated over time. Relapse chemotherapy, central nervous system irradiation, hematopoietic stem cell transplantation and total body irradiation are associated with greater risk of long-term complications...
January 16, 2024: Blood
https://read.qxmd.com/read/38211337/how-we-use-genomics-and-btk-inhibitors-in-the-treatment-of-waldenstrom-macroglobulinemia
#23
JOURNAL ARTICLE
Steven P Treon, Shayna Sarosiek, Jorge J Castillo
Mutations in MYD88 (95-97%) and CXCR4 (30-40%) are common in Waldenstrom macroglobulinemia (WM). TP53 is also altered in 20-30% of WM patients, particularly those previously treated. Mutated MYD88 upregulates and activates HCK that drives BTK pro-survival signaling. Both nonsense and frameshift CXCR4 mutations occur in WM. Nonsense variants such as CXCR4S338X show greater resistance to BTK-inhibitors. Covalent BTK-inhibitors (cBTK-i) produce major responses in 70-80% of WM patients. MYD88 and CXCR4 mutation status can impact time to major response, depth of response and/or progression-free survival (PFS) in WM patients treated with cBTK-i...
January 11, 2024: Blood
https://read.qxmd.com/read/38145575/how-i-treat-myeloproliferative-neoplasms-in-pregnancy
#24
JOURNAL ARTICLE
Susan Robinson, Monica Ragheb, Claire N Harrison
Whilst MPN are traditionally considered diseases of adults in their sixth or seventh decade these conditions do occur in young patients for example for essential thrombocythaemia in particular there is a second peak in women of reproductive age. Pregnancy therefore is an uncommon but not rare occurrence and clinical challenge in some scenarios. Here we discuss in detail our local approach to the management of pregnancy in MPN patients taking a case-based approach. We take time to include relevant updates in the field and point to a future research strategy which should be internationally focused in order to obtain as much information in as short a time as possible...
December 25, 2023: Blood
https://read.qxmd.com/read/38145574/how-i-diagnose-and-treat-antiphospholipid-syndrome-in-pregnancy
#25
JOURNAL ARTICLE
D Ware Branch, Ming Y Lim
Antiphospholipid syndrome (APS) is a rare autoimmune disease characterized by arterial, venous, or microvascular thrombosis, pregnancy morbidities, or nonthrombotic manifestations in patients with persistently positive antiphospholipid antibodies. These antibodies bind cellular phospholipids and phospholipid-protein complexes resulting in cellular activation and inflammation that lead to the clinical features of APS. Our evolving understanding of APS has resulted in more specific classification criteria. Patients meeting these criteria should be treated during pregnancy according to current guidelines...
February 29, 2024: Blood
https://read.qxmd.com/read/38132422/assessing-the-antioxidant-benefits-of-topical-carvacrol-and-magnolol-periodontal-hydrogel-therapy-in-periodontitis-associated-with-diabetes-in-wistar-rats
#26
JOURNAL ARTICLE
Georgiana Ioana Potra Cicalău, Gabriela Ciavoi, Ioana Scrobotă, Andreea Olivia Marcu, Ioana Romanul, Eleonora Marian, Laura Grațiela Vicaș, Mariana Ganea
It is well recognized that oxidative stress contributes to chronic stress-induced cytotoxicity, which is a major factor in the progression of many diseases, including periodontitis and diabetes. Formulas based on natural extracts with antioxidant properties are alternative treatment perspectives in the management of such diseases. The aim of our study was to assess how carvacrol and magnolol influence periodontitis associated with diabetes in Wistar rats. Ninety Wistar rats were distributed in nine groups: I-control group; II-diabetes group (D); III-periodontitis group (P); IV-periodontitis and diabetes group (PD); V-periodontitis and diabetes with vehicle alone (PDV); VI-periodontitis and diabetes treated with carvacrol (PDC); VII-periodontitis and diabetes treated with magnolol (PDM); VIII-periodontitis and diabetes treated with carvacrol and magnolol (PDCM); IX-healthy group with vehicle alone (CV)...
December 8, 2023: Dentistry Journal
https://read.qxmd.com/read/38132338/the-oxygen-ozone-adjunct-medical-treatment-according-to-the-protocols-from-the-italian-scientific-society-of-oxygen-ozone-therapy-how-ozone-applications-in-the-blood-can-influence-clinical-therapy-success-via-the-modulation-of-cell-biology-and-immunity
#27
JOURNAL ARTICLE
Salvatore Chirumbolo, Luigi Valdenassi, Umberto Tirelli, Giovanni Ricevuti, Sergio Pandolfi, Francesco Vaiano, Antonio Galoforo, Fortunato Loprete, Vincenzo Simonetti, Marianna Chierchia, Debora Bellardi, Tommaso Richelmi, Marianno Franzini
BACKGROUND: Ozone is an allotrope of oxygen whose use in medicine has rapidly grown in recent years. Ozonated blood allows for the use of ozone in a safe modality, as plasma and blood cells are endowed with an antioxidant system able to quench ozone's pro-oxidant property and to elicit the Nrf2/Kwap1/ARE pathway. METHODS: We present two clinical studies, a case-series (six patients) observational study adopting ozone as a major autohemotherapy and topical ozone to address infected post-surgical wounds with multi-drug resistant bacteria and an observational study (250 patients) using ozonated blood for treating knee osteoarthritis...
December 11, 2023: Biology
https://read.qxmd.com/read/38074148/total-flavonoids-extracted-from-penthorum-chinense-pursh-mitigates-ccl-4-induced-hepatic-fibrosis-in-rats-via-inactivation-of-tlr4-myd88-mediated-nf-%C3%AE%C2%BAb-pathways-and-regulation-of-liver-metabolism
#28
JOURNAL ARTICLE
Sujuan Wang, Wenqing Li, Wenxiu Liu, Lei Yu, Fu Peng, Junyuan Qin, Lin Pu, Yunli Tang, Xiaofang Xie, Cheng Peng
Background: Penthorum chinense Pursh (PCP) is widely utilized in China to treat a variety of liver diseases. It has been shown that flavonoids inhibit inflammation and have the potential to attenuate tissue damage and fibrosis. However, the mechanisms underlying how total flavonoids isolated from PCP (TFPCP) exert their anti-fibrotic effects remain unclear. Methods: The chemical composition of TFPCP was determined using UHPLC-Q-Orbitrap HRMS. Subsequently, rats were randomly assigned to a control group (Control), a carbon tetrachloride (CCl4 )-induced hepatic fibrosis model group (Model), a positive control group [0...
2023: Frontiers in Pharmacology
https://read.qxmd.com/read/38045996/drugs-with-a-negative-impact-on-cognitive-function-part-1-chronic-kidney-disease-as-a-risk-factor
#29
REVIEW
Sophie Liabeuf, Vesna Pešić, Goce Spasovski, Romaldas Maciulaitis, Mickaël Bobot, Ana Farinha, Carsten A Wagner, Robert J Unwin, Giovambattista Capasso, Inga Arune Bumblyte, Gaye Hafez
People living with chronic kidney disease (CKD) frequently suffer from mild cognitive impairment and/or other neurocognitive disorders. This review in two parts will focus on adverse drug reactions resulting in cognitive impairment as a potentially modifiable risk factor in CKD patients. Many patients with CKD have a substantial burden of comorbidities leading to polypharmacy. A recent study found that patients seen by nephrologists were the most complex to treat because of their high number of comorbidities and medications...
December 2023: Clinical Kidney Journal
https://read.qxmd.com/read/38044048/-expert-consensus-on-the-management-of-interstitial-lung-disease-during-the-covid-19-epidemic
#30
JOURNAL ARTICLE
(no author information available yet)
Coronavirus disease 2019(COVID-19) is prevalent around the world, and pre-existing ILD is associated with increased severity and mortality of COVID-19. However, the current knowledge on the management strategy for COVID-19 patients with pre-existing interstitial lung disease (ILD) is very limited. There is still a need for consensus on treatments for these patients. In addition, ILD that occurs after the acute phase of COVID-19 (Post-acute Covid-19 ILD, PC-ILD) is also very common, and how to manage PC-ILD is also under debate...
December 12, 2023: Chinese Journal of Tuberculosis and Respiratory Diseases
https://read.qxmd.com/read/37992219/how-i-treat-thrombocytopenia-in-pregnancy
#31
REVIEW
Annemarie E Fogerty, David J Kuter
Thrombocytopenia is a common hematologic abnormality in pregnancy, encountered in ∼10% of pregnancies. There are many possible causes, ranging from benign conditions that do not require intervention to life-threatening disorders necessitating urgent recognition and treatment. Although thrombocytopenia may be an inherited condition or predate pregnancy, most commonly it is a new diagnosis. Identifying the responsible mechanism and predicting its course is made challenging by the tremendous overlap of clinical features and laboratory data between normal pregnancy and the many potential causes of thrombocytopenia...
February 29, 2024: Blood
https://read.qxmd.com/read/37986029/personalized-therapy-in-rheumatoid-arthritis-petra-a-protocol-for-a-randomized-controlled-trial-to-test-the-effect-of-a-psychological-intervention-in-rheumatoid-arthritis
#32
JOURNAL ARTICLE
Lennart Seizer, Ellis Huber, Miriam Schirmer, Sven Hilbert, Eva-Maria Wiest, Christian Schubert
Rheumatoid arthritis (RA) is a chronic autoimmune disease that primarily affects cartilage and bone. Psychological stress can both trigger disease exacerbation and result from disease activity. As standard pharmacological interventions alone have limited success in treating RA, a more comprehensive biopsychosocial approach to treatment has been recommended. In this prospective randomized controlled trial (RCT), a psychotherapeutically guided, group-based intervention program will be conducted with RA patients over a period of 9 months...
November 20, 2023: Trials
https://read.qxmd.com/read/37982033/metabolic-profiles-associated-with-opioid-use-and-opioid-use-disorder-a-narrative-review-of-the-literature
#33
JOURNAL ARTICLE
Juliana I Byanyima, Xinyi Li, Sianneh A Vesslee, Henry R Kranzler, Zhenhao Shi, Corinde E Wiers
PURPOSE OF REVIEW: Opioid use disorder (OUD) is a chronic, relapsing condition that is epidemic in the USA. OUD is associated with serious adverse consequences, including higher incarceration rates, impaired medical and mental health, and overdose-related fatalities. Several medications with demonstrated clinical efficacy in reducing opioid use are approved to treat OUD. However, there is evidence that medications for OUD cause metabolic impairments, which raises concerns over the long-term metabolic health of individuals recovering from OUD...
September 2023: Current Addiction Reports
https://read.qxmd.com/read/37967664/neuronanomedicine-for-alzheimer-s-and-parkinson-s-disease-current-progress-and-a-guide-to-improve-clinical-translation
#34
JOURNAL ARTICLE
India Boyton, Stella M Valenzuela, Lyndsey E Collins-Praino, Andrew Care
Neuronanomedicine is an emerging multidisciplinary field that aims to create innovative nanotechnologies to treat major neurodegenerative disorders, such as Alzheimer's (AD) and Parkinson's disease (PD). A key component of neuronanomedicine are nanoparticles, which can improve drug properties and demonstrate enhanced safety and delivery across the blood brain barrier, a major improvement on existing therapeutic approaches. In this review, we critically analyze the latest nanoparticle-based strategies to modify underlying disease pathology to slow or halt AD/PD progression...
November 13, 2023: Brain, Behavior, and Immunity
https://read.qxmd.com/read/37961215/expansion-of-endogenous-t-cells-in-csf-of-pediatric-cns-tumor-patients-undergoing-locoregional-delivery-of-il13r%C3%A2-%C2%BA2-targeting-car-t-cells-an-interim-analysis
#35
Leo Wang, Angela Taravella Oill, M Blanchard, Melody Wu, Jonathan Hibbard, Sean Sepulveda, Lance Peter, Julie Kilpatrick, Margarita Munoz, Tracey Stiller, Noah Shulkin, Jamie Wagner, Ally Dolatabadi, Monica Nisis, Jennifer Shepphird, Gabriela Sanchez, Chetan Lingaraju, Mishika Manchanda, Heini Natri, Léonce Kouakanou, Grace Sun, Cheryl Oliver-Cervantes, Joseph Georges, Maryam Aftabizadeh, Stephen Forman, Saul Priceman, Julie Ressler, Leonidas Arvanitis, Jennifer Cotter, Massimo D'Apuzzo, Benita Tamrazi, Behnam Badie, Tom Davidson, Nicholas Banovich, Christine Brown
Outcomes for pediatric brain tumor patients remain poor, and there is optimism that chimeric antigen receptor (CAR) T cell therapy can improve prognosis. Here, we present interim results from the first six pediatric patients treated on an ongoing phase I clinical trial (NCT04510051) of IL13BBζ-CAR T cells delivered weekly into the lateral cerebral ventricles, identifying clonal expansion of endogenous CAR-negative CD8 + T cells in the cerebrospinal fluid (CSF) over time. Additionally, of the five patients evaluable for disease response, three experienced transient radiographic and/or clinical benefit not meeting protocol criteria for response...
October 23, 2023: Research Square
https://read.qxmd.com/read/37956435/how-i-diagnose-and-treat-thrombocytopenia-in-geriatric-patients
#36
JOURNAL ARTICLE
Patrick Foy, Kenneth D Friedman, Laura C Michaelis
Thrombocytopenia in older individuals is a common but diagnostically challenging condition that has variable clinical impact to those who are affected. Diagnostic approach requires evaluation of the preexisting clinical conditions, detailed review of medications, and assessment for disorders that warrant urgent treatment. In this article, we describe a systematic approach to diagnosis of thrombocytopenia and present a schematic review for management strategies. Three clinical scenarios are presented that are relevant for their prevalence and management challenges in an older adult population...
January 18, 2024: Blood
https://read.qxmd.com/read/37944143/how-i-treat-refractory-and-relapsed-acute-myeloid-leukemia
#37
JOURNAL ARTICLE
Felicitas Thol, Hartmut Döhner, Arnold Ganser
Most patients with acute myeloid leukemia (AML) develop refractory/relapsed (R/R) disease even in the presence of novel and targeted therapies. Given the biological complexity of the disease and differences in frontline treatments, there are therapies approved for only subgroups of R/R AML, and enrollment in clinical trials should be first priority. Allogeneic hematopoietic cell transplantation (HCT) is the only potentially curative strategy for most patients. Therapeutic approaches, including allogeneic HCT, triggered by the presence of measurable residual disease (MRD), have recently evolved to prevent overt hematologic relapse...
January 4, 2024: Blood
https://read.qxmd.com/read/37841434/leukemic-conversion-involving-ras-mutations-of-type-1-calr-mutated-primary-myelofibrosis-in-a-patient-treated-for-hcv-cirrhosis-a-case-report
#38
Petruta Gurban, Cristina Mambet, Anca Botezatu, Laura G Necula, Ana I Neagu, Lilia Matei, Ioana M Pitica, Saviana Nedeianu, Mihaela Chivu-Economescu, Coralia Bleotu, Marius Ataman, Gabriela Mocanu, Carmen Saguna, Anca G Pavel, Danae Stambouli, Elise Sepulchre, Gabriela Anton, Carmen C Diaconu, Stefan N Constantinescu
Somatic frameshift mutations in exon 9 of calreticulin ( CALR ) gene are recognized as disease drivers in primary myelofibrosis (PMF), one of the three classical Philadelphia-negative myeloproliferative neoplasms (MPNs). Type 1/type 1-like CALR mutations particularly confer a favorable prognostic and survival advantage in PMF patients. We report an unusual case of PMF incidentally diagnosed in a 68-year-old woman known with hepatitis C virus (HCV) cirrhosis who developed a progressive painful splenomegaly, without anomalies in blood cell counts...
2023: Frontiers in Oncology
https://read.qxmd.com/read/37837179/educational-and-occupational-outcomes-in-swedish-children-treated-for-sarcomas-a-nationwide-registry-based-study
#39
JOURNAL ARTICLE
Albin Grundström, Arja Harila, Malin Lönnerblad
BACKGROUND: Many children treated for cancer experience a negative impact on their academic performance; however, most studies of children treated for sarcomas have not investigated academic performance. Our aim was to explore how Swedish children treated for sarcomas perform academically, as well as how they adjust to life afterwards. PROCEDURE: We compared 167 pediatric sarcoma survivors with 776 matched, non-sibling controls without a history of cancer, in a retrospective cohort study using data from nationwide registries...
October 13, 2023: Pediatric Blood & Cancer
https://read.qxmd.com/read/37800608/plasma-metabonomic-study-on-the-effect-of-para-%C3%A2-hydroxybenzaldehyde-intervention-in-a-rat-model-of-transient-focal-cerebral-ischemia
#40
JOURNAL ARTICLE
Xinglin Yu, Yuan Luo, Liping Yang, Xiaohua Duan
Gastrodia elata Blume has been widely used to treat various central and peripheral nerve diseases, and Para‑hydroxybenzaldehyde (PHBA) is one of the indicated components suggested to provide a neuroprotective effect. In our previous, it was shown that PHBA protected mitochondria against cerebral ischemia‑reperfusion (I/R) injury in rats. In the present study, how PHBA regulated the metabolic mechanism in blood following cerebral I/R was assessed to identify an effective therapeutic target for the prevention and treatment of ischemic stroke (IS)...
November 2023: Molecular Medicine Reports
keyword
keyword
66005
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.